GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Gross Margin %

Tatva Chintan Pharma Chem (BOM:543321) Gross Margin % : 57.79% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Tatva Chintan Pharma Chem's Gross Profit for the three months ended in Mar. 2024 was ₹568 Mil. Tatva Chintan Pharma Chem's Revenue for the three months ended in Mar. 2024 was ₹983 Mil. Therefore, Tatva Chintan Pharma Chem's Gross Margin % for the quarter that ended in Mar. 2024 was 57.79%.


The historical rank and industry rank for Tatva Chintan Pharma Chem's Gross Margin % or its related term are showing as below:

BOM:543321' s Gross Margin % Range Over the Past 10 Years
Min: 42.55   Med: 46.65   Max: 55.74
Current: 55.74


During the past 6 years, the highest Gross Margin % of Tatva Chintan Pharma Chem was 55.74%. The lowest was 42.55%. And the median was 46.65%.

BOM:543321's Gross Margin % is ranked better than
94.7% of 1510 companies
in the Chemicals industry
Industry Median: 22.355 vs BOM:543321: 55.74

Tatva Chintan Pharma Chem had a gross margin of 57.79% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Tatva Chintan Pharma Chem was 4.30% per year.


Tatva Chintan Pharma Chem Gross Margin % Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Gross Margin % Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial 46.28 46.66 51.85 46.63 55.74

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.76 49.24 61.40 55.65 57.79

Competitive Comparison of Tatva Chintan Pharma Chem's Gross Margin %

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's Gross Margin % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Gross Margin % falls into.



Tatva Chintan Pharma Chem Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Tatva Chintan Pharma Chem's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=2193.2 / 3935.04
=(Revenue - Cost of Goods Sold) / Revenue
=(3935.04 - 1741.82) / 3935.04
=55.74 %

Tatva Chintan Pharma Chem's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=567.9 / 982.66
=(Revenue - Cost of Goods Sold) / Revenue
=(982.66 - 414.78) / 982.66
=57.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Tatva Chintan Pharma Chem  (BOM:543321) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Tatva Chintan Pharma Chem had a gross margin of 57.79% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Tatva Chintan Pharma Chem Gross Margin % Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines